VANGUARD GROUP INC 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:12 pm Sale | 2026-03-13 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 0 0.000% | -10,639,440 (Position Closed) | Filing |
| 2024-11-12 1:30 pm Unchanged | 2024-09-30 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 10,639,440 7.210% | 0 (Unchanged) | Filing |
| 2024-11-04 10:58 am Sale | 2024-09-30 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 10,639,440 7.210% | -2,128,244 (-16.67%) | Filing |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 12,767,684 8.820% | 973,516 (+8.25%) | Filing |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 11,794,168 8.250% | 762,880 (+6.92%) | Filing |
| 2022-02-09 3:16 pm Purchase | 2021-12-31 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 11,031,288 7.820% | 1,375,863 (+14.25%) | Filing |